Factor IX polypeptide formulations
US10588949B2 · kind B2 · utility
3Cited by
17References
42Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 14, 2014 |
| Grant date | Mar 17, 2020 |
| Priority date | — |
| Expiry date | Nov 28, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides formulations comprising a Factor IX-FcRn Binding Partner (FIXFBP) polypeptide, and methods of administering FIXFBP.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.